作者: Christine C Ginocchio , Angela M Caliendo , Robert C Colgrove , Nira R Pollock , Andrew Chou
DOI: 10.1093/OFID/OFAB095
关键词:
摘要: Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in symptomatic and asymptomatic patients is an important component of the multifaceted approach managing disease 2019 pandemic. Determining how to best define testing strategies different populations incorporating these into broader infection prevention programs can be complex. Many circumstances are not addressed by federal, local, or professional guidelines. This commentary describes various scenarios which individuals SARS-CoV-2 virus (antigen ribonucleic acid) potential benefit. Consideration pretest probability, risks (impact false-positive false-negative results), strategy, as well action based on test results explored. Testing, regardless setting, must incorporated overarching control plans, include use personal protective equipment (eg, masks), physically distancing, isolation when exposure suspected.